1-9 of 9
Qi-long Yi
Close
Sort by
Journal Articles

Clinical Relevance of Cytogenetics Abnormalities in Adult Patients with Acquired Aplastic Anaemia.

Vikas Gupta, Carol Brooker, Jennifer A. Tooze, Qi-long Yi, Deborah Sage, David Turner, Pamela Kangasabapathy, Judith C.W. Marsh
Journal: Blood
Blood (2005) 106 (11): 3748.
https://doi.org/10.1182/blood.V106.11.3748.3748
Published: 2005
Journal Articles

Prognostic Relevance of CD56 Expression in Patients with Multiple Myeloma Treated with High-Dose Melphalan-Based Chemotherapy and Autologous Stem Cell Transplant.

Joanna Yeung, Sara Samiee, Qi Long Yi, Dominic Pantalony, Hong Chang
Journal: Blood
Blood (2005) 106 (11): 5086.
https://doi.org/10.1182/blood.V106.11.5086.5086
Published: 2005
Journal Articles

Immunohistochemistry accurately predicts FGFR3 aberrant expression and t(4;14) in multiple myeloma

Brief Report
Hong Chang, A. Keith Stewart, Xiao Ying Qi, Zhi Hua Li, Qi Long Yi, Suzanne Trudel
Journal: Blood
Blood (2005) 106 (1): 353–355.
https://doi.org/10.1182/blood-2005-01-0033
Published: 2005
Journal Articles

p53 gene deletion detected by fluorescence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantation

Brief Report
Hong Chang, Connie Qi, Qi-Long Yi, Donna Reece, A. Keith Stewart
Journal: Blood
Blood (2005) 105 (1): 358–360.
https://doi.org/10.1182/blood-2004-04-1363
Published: 2005
Journal Articles

Thrombotic Events in Adults with Acute Lymphoblastic Leukemia.

Christine M. Cserti, MD, Joseph Brandwein, MD, Jeffrey H. Lipton, MD, PhD, Anne G. McLeod, MD, Hans Messner, MD, PhD, Mark D. Minden, MD, PhD, Aaron D. Schimmer, MD, PhD, Andre C. Schuh, MD, PhD, Jack T. Seki, PharmD, Erik L. Yeo, MD, Qi-Long Yi, PhD, Richard A. Wells, MD, DPhil
Journal: Blood
Blood (2004) 104 (11): 2734.
https://doi.org/10.1182/blood.V104.11.2734.2734
Published: 2004
Journal Articles

A Phase II Study of Peripheral Blood Stem Cell (PBSC) Mobilization Using Stem Cell Factor (SCF), Filgrastin (G-CSF), and Cyclophosphamide (CY) in Patients at High Risk for Mobilization Failure.

Christine I. Chen, MD, Tracy Nagy, Qi-long Yi, Armand Keating, MD, Michael Crump, MD
Journal: Blood
Blood (2004) 104 (11): 2883.
https://doi.org/10.1182/blood.V104.11.2883.2883
Published: 2004
Journal Articles

P53 Gene Deletion Detected by Fluorescence In Situ Hybridization Is an Adverse Prognostic Factor for Patients with Multiple Myeloma Following Autologous Stem Cell Transplantation.

Xiao Ying Qi, Qi Long Yi, Donna Reece, A. Keith Stewart, Hong Chang
Journal: Blood
Blood (2004) 104 (11): 4884.
https://doi.org/10.1182/blood.V104.11.4884.4884
Published: 2004
Journal Articles

t(11;14) Is Infrequent in Long-Term Myeloma Survivors.

Hong Chang, Sara Samiee, Xiao Ying Qi, Qi Long Yi, A. Keith Stewart
Journal: Blood
Blood (2004) 104 (11): 4890.
https://doi.org/10.1182/blood.V104.11.4890.4890
Published: 2004
Journal Articles

Favourable Impact on Acute and Chronic Graft-Versus-Host Disease with Cyclophosphamide and In-Vivo Anti-CD52 Monoclonal Antibodies for Marrow Transplantation from HLA-Identical Sibling Donors for Acquired Aplastic Anaemia.

Vikas Gupta, Sarah E. Ball, Qi-long Yi, Deborah Sage, Shaun R. McCann, Mark Lawler, Miguel Ortin, Mylene Freires, Geoff Hale, Hermann Waldmann, Edward C. Gordon-Smith, Judith C.W. Marsh
Journal: Blood
Blood (2004) 104 (11): 3333.
https://doi.org/10.1182/blood.V104.11.3333.3333
Published: 2004